Age Perception, Millennial Generation in the Presidential Election

  Age is an attractive factor in the 2019 presidential election compared to our previous elections. Two pairs of presidential and vice-presidential candidates have an age range that has been widely discussed in political conversation. Joko “Jokowi” Widodo, 57 years old (born on June 21, 1961), pairs up with Ma’ruf Amin, and Prabowo Subianto, 66 years old (born on October 17, 1951), pairs with Sandiaga Uno. Meanwhile, at present it is known that there is a thick layer of the millennial generation that is believed to be able to determine the direction of the presidential election with more than 40 percent of voters. The millennial generation is a bone of contention for the two camps even though in their calculations they use the opposite strategies. Jokowi chooses 75-year-old Ma’ruf (born March 11, 1943) and Prabowo appointed Sandiaga, who has a much younger age, 49 years old (born June 28, 1969).

The Race to Creating a Vaccine

We are seeing many countries accelerating Covid-19 vaccine development, a race that has become increasingly fierce. We are seeing many countries accelerating Covid-19 vaccine development, a race that has become increasingly fierce. Many comments, criticisms and praises have been made regarding this endeavor. Social media is also full of knowledgeable opinions. However, many people are also giving praise or criticism without any deep insight on this issue. Let us use a cool head in an attempt to understand the “vaccine race” to control the disease, which is now infecting almost 300,000 people every day. Russian President Vladimir Putin recently announced on 11 Aug. that his country had become the first to successfully develop a vaccine. This vaccine will soon be used for mass immunization in October. Putin claims that the vaccine is safe, and that his own daughter volunteered in the clinical trial.

Early Detection of Silent Hypoxia

The development of Covid-19 has brought forth a new phenomenon that is increasingly challenging. The development of Covid-19 has brought forth a new phenomenon that is increasingly challenging. Three patients in Banyumas reportedly appeared asymptomatic but then suddenly died. According to a statement of Banyumas Regent Achmad Husein, all three of them seemed happy before they died. Unlike other Covid-19 patients, they had not shown any symptoms of cough, flu or fever. However, the oxygen saturation (the percentage of red blood cells that bind oxygen) continued to decline, leading to breathing failure. An examination then confirmed that the three were Covid-19 positive. This is what the public calls the “happy hypoxia” syndrome. This syndrome is reported to have afflicted many Covid-19 patients. Before the pandemic, it has also been seen in other lung infections, atelectasis and intrapulmonary shunts, but it has increased rapidly because of Covid-19.

Being Agile Against the Pandemic

Only a day after declaring the COVID-19 outbreak a pandemic (11/3/2020), director general of the World Health Organization, Tedros Adhanom Ghebreyesus, sent a letter to President Jokowi. The WHO asked that President Jokowi immediately declare a national emergency; build a laboratory of adequate scale; expand case search, tracking, monitoring and careful data collection; and intensify preventive measures, including by encouraging people to wash their hands frequently. However, this is an “exasperated” response on the part of WHO to see Indonesia’s response, which was considered too relaxed. For more than two months, the Health Ministry boasted a zero status of positive COVID-19 cases. However, on Monday (2/3/2020), two weeks ago, the defense was broken. The President announced that two Indonesian citizens had tested positive for COVID-19. There was a Japanese citizen visiting Indonesia, then continuing to Singapore. A careful examination in Singapore confirmed that the Japanese had tested positive for COVID-19. Tracking was later conducted in Indonesia on someone who made contact with the Japanese citizen. The person was found and tested positive for being infected, then the President announced it.

Hope from Blood Plasma

The super-virus that causes COVID-19 in Indonesia is taking more and more victims and is estimated to have not yet reached its peak. In the midst of this difficulty is some good news, like a light at the end of the tunnel. The Eijkman Institute of Molecular Biology immediately started the treatment of COVID-19 patients using blood plasma from patients who have been declared healthy. This method can be called plasma recovery. On Monday (20/4/2020), head of the Eijkman Institute of Molecular Biology Amin Subandrio said his agency, with the support of the Food and Drug Agency (Badan POM) and the Health Ministry, was ready to implement the plasma recovery method treatment in the coming weeks. On Tuesday (28/4), Kompas reported, state-owned pharmaceutical company PT Biopharma and Gatot Soebroto Army Hospital joined in this fast-moving innovation.